Moreover, augmented urotensin signaling in TSC or LAM tumors is consistent with the expression of other immature neural crest markers (e.g., gp100, tyrosinase), and its role in other neoplasias of neural or endocrine lineage [39, 46, 47]. The gene discussed is PMEL; the disease is lymphangioleiomyomatosis.